Contract award record
CM/PHR/23/5702 - NHS National Framework for Tocilizumab - March 2024
Notice details
- Published
- Category
- goods
- Buyer region
- North West
- Source
- View official notice
Public buyer and contract winner
Public buyer
02182135awarded to
Contract winner
Roche Products LtdAward value£46,600,000
- StartCompleted
- AwardedCompleted
- EndCompleted
Work description
Project Title: NHS National Framework for Tocilizumab - March 2024
Offer reference number: CM/PHR/23/5702
CM/PHR/23/5702/01 NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
CM/PHR/23/5702/02 NHS Framework for Tocilizumab NORTH OF ENGLAND and MIDLANDS AND EAST. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.